REFERENCES
- Liao M.L, Cheng B.J, The clinical progress of chemother-apy in non-small cell lung cancer. Chin J Tuberculosis Resp Dis, 2004; 27: 480–482.
- Panthong A, Norkaew P, Kanjanapothi D, Taesotikul T, Anantachoke N, Reutrakul V. Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook. J Ethnopharmacol 2007; 111: 335–340.
- Guo ZL, Wu QL, You ZQ, Yu QD, Zhang GQ. Effect of gambogic acid on the hemopoietic and immune functions in ex-perimental animals. Chin J Nat Med 2003; 1: 229–232.
- Kasibhatla S, Jessen KA, Maliartchouk S, Wang JY, Eng-lish NM, Drewe J, et al. A role for transferrin receptor in trig-gering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA. 2005; 102: 12095–12100.
- Chen J, Gu HY, Lu N, Yang Y, Liu W, Qi Q, et al. Micro-tubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. Life Sci. 2008; 83: 103–109.
- Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY, et al Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells.Cancer Chemother Pharmacol. 2006; 58: 434–443.
- Qiang L, Yang Y, You QD, Ma YJ, Yang L, Nie FF, et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study. Biochem Pharmacol. 2008; 75: 1083–1092.
- Qin YX, Meng LH, Hu Chaoxin, Duan WH, Zuo ZL, Lin LP, et al. Gambogic acid inhibits the catalytic activity of human topoisomerase IIA by binding to its ATPase domain. Mol Cancer Ther 2007; 6: 2429–2440.
- Gu HY, You QD, Liu W, Yang Y, Zhao L, Qi Q, et al. Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice. Int Immunopharmacol 2008; 8: 1493-1502.
- Chen X, Park R, Shahinian AH, Bading JR, Conti PS. Pharmacokinetics and tumor retention of 1251-labeled RGD pep-tide are improved by PEGylation. Nucl Med Biol 2004; 31: 11–19.
- Gomme PT, McCann KB, Bertolini J Transferrin: struc-ture, function and potential therapeutic actions. Drug Discov Today, 2005; 10 :267–273.
- Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipan-cic I, Zarkovic N. Altered iron metabolism, transferring receptor 1 and ferritin in patients with colon cancer. Cancer Lett 2006; 238: 188–196.
- Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and target-ing with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006; 121: 144–158.
- Yang Y, Yang L, You QD, et al. Differential apoptotic in-duction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytesCancer Lett2007; 256: 259–66.
- Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF induced apoptosisthrough modulation of the nuclear factor-lkappalB signaling pathway. Blood 2007; 110: 3517–3525.
- Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Caspase 10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 2002; 21: 4520-4530.
- Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase 10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001; 98: 13884–13888.
- Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, et al. Pro-caspase-3 is a major physiologic tar-get of caspase-8. J Biol Chem 1998; 273: 27084–27090.
- Shu KX, Li B, Wu LX. The p53 network: p53 and its downstream genes. Colloids Surf B Biointerfaces 2007; 55: 10–8.